Firebrick Pharma Limited (ASX:FRE)
Australia
· Delayed Price · Currency is AUD 0.0660
0.00 (0.00%)
May 28, 2025, 10:51 AM AEST
Firebrick Pharma Revenue
Firebrick Pharma had revenue of 197.07K AUD in the half year ending December 31, 2024, with 773.92% growth. This brings the company's revenue in the last twelve months to 1.13M, down -37.71% year-over-year. In the fiscal year ending June 30, 2024, Firebrick Pharma had annual revenue of 2.75M with 12,096.48% growth.
Revenue (ttm)
1.13M
Revenue Growth
-37.71%
P/S Ratio
13.10
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.82M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |